Turnstone Biologics Corp.
TSBXDelisted Aug 11, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764974
Turnstone Biologics Corp. was delisted on Aug 11, 2025; its insiders filed their last Form 4 on Aug 12, 2025; 23 institutions reported holding it in 13F filings for Q2 2025, worth $3.03M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Turnstone Biologics Corp. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 24
- −22 vs. Q2 2024
- Shares held
- 11.4M
- −1.22M (−9.6%) vs. Q2 2024
- Total value
- $6.37M
- −$26.8M (−80.8%) vs. Q2 2024
- New holders
- 2
- 5 more added
- Sold out
- 24
- 10 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TSBX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 23 | $3.03M |
| Q1 2025 | 23 | $4.26M |
| Q4 2024 | 28 | $5.51M |
| Q3 2024 | 24 | $6.37M |
| Q2 2024 | 47 | $33.3M |
| Q1 2024 | 40 | $35.0M |
| Q4 2023 | 36 | $33.1M |
| Q3 2023 | 35 | $48.0M |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Turnstone Biologics Corp.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 3,099,265 | $1.73M | 0.03% | 00.0% | Unchanged |
| FMR LLC | 1,172,987 | $653.5K | 0.00% | +37,738+3.3% | Added |
| PFM Health Sciences, LP | 932,348 | $519.4K | 0.03% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 932,226 | $519.3K | 0.00% | −186,362−16.7% | Reduced |
| Bank of America Corp | 911,741 | $507.8K | 0.00% | +960+0.1% | Added |
| Takeda Pharmaceutical Co Ltd | 895,824 | $499.0K | 1.31% | 00.0% | Unchanged |
| Citadel Advisors LLC | 689,213 | $384.0K | 0.00% | +4,580+0.7% | Added |
| Vanguard Group Inc | 578,995 | $322.5K | 0.00% | 00.0% | Unchanged |
| 72 Investment Holdings, LLC | 549,980 | $306.4K | 0.66% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 517,648 | $288.4K | 0.17% | 00.0% | Unchanged |
| ExodusPoint Capital Management, LP | 454,026 | $253.0K | 0.00% | −10,795−2.3% | Reduced |
| FIL Ltd | 192,657 | $107.3K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 132,819 | $74.0K | 0.00% | +60,867+84.6% | Added |
| Barclays PLC | 110,044 | $61.3K | 0.00% | −5,934−5.1% | Reduced |
| Millennium Management LLC | 103,028 | $57.4K | 0.00% | −22,829−18.1% | Reduced |
| Balyasny Asset Management LLC | 49,880 | $27.8K | 0.00% | −3,802−7.1% | Reduced |
| BlackRock, Inc. | 42,928 | $23.9K | 0.00% | +42,928 | New |
| Acadian Asset Management LLC | 36,454 | $19.0K | 0.00% | +36,454 | New |
| Northern Trust Corp | 18,405 | $10.3K | 0.00% | −75,829−80.5% | Reduced |
| UBS Group AG | 10,643 | $5.93K | 0.00% | +9,092+586.2% | Added |
| Morgan Stanley | 6,001 | $3.34K | 0.00% | −12,758−68.0% | Reduced |
| Tower Research Capital LLC (TRC) | 4,976 | $2.77K | 0.00% | −5,526−52.6% | Reduced |
| Catalyst Funds Management Pty Ltd | 800 | $446 | 0.00% | −3,100−79.5% | Reduced |
| JPMorgan Chase & Co | 158 | $88 | 0.00% | −6,683−97.7% | Reduced |
| Eventide Asset Management, LLC | 0 | $0 | 0.00% | −458,317−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −216,138−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −73,288−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −51,293−100.0% | Sold out |
| Kathleen S. Wright Associates Inc. | 0 | $0 | 0.00% | −42,553−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −36,609−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −35,771−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −25,225−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −24,900−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −24,825−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,025−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −15,018−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −13,954−100.0% | Sold out |
| O'Shaughnessy Asset Management, LLC | 0 | $0 | 0.00% | −13,737−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −11,882−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −8,135−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −2,445−100.0% | Sold out |
| Nordwand Advisors, LLC | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −860−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −789−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −54−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −11−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |